An anticancer agent, pyrvinium pamoate inhibits the NADH–fumarate reductase system—a unique mitochondrial energy metabolism in tumour microenvironments
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Increased glycolysis is the principal explanation for how cancer cells generate energy in the absence of oxygen. However, in actual human tumour microenvironments, hypoxia is often associated with hypoglycemia because of the poor blood supply. Therefore, glycolysis cannot be the sole mechanism for the maintenance of the energy status in cancers. To understand energy metabolism in cancer cells under hypoxia-hypoglycemic conditions mimicking the tumour microenvironments, we examined the NADH-fumarate reductase (NADH-FR) system, which functions in parasites under hypoxic condition, as a candidate mechanism. In human cancer cells (DLD-1, Panc-1 and HepG2) cultured under hypoxic-hypoglycemic conditions, NADH-FR activity, which is composed of the activities of complex I (NADH-ubiquinone reductase) and the reverse reaction of complex II (quinol-FR), increased, whereas NADH-oxidase activity decreased. Pyrvinium pamoate (PP), which is an anthelmintic and has an anti-cancer effect within tumour-mimicking microenvironments, inhibited NADH-FR activities in both parasites and mammalian mitochondria. Moreover, PP increased the activity of complex II (succinate-ubiquinone reductase) in mitochondria from human cancer cells cultured under normoxia-normoglycemic conditions but not under hypoxia-hypoglycemic conditions. These results indicate that the NADH-FR system may be important for maintaining mitochondrial energy production in tumour microenvironments and suggest its potential use as a no…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tomitsuka, Kita, and Esumi [11] compared its effects under hypoxic‐hypoglycaemic conditions, which mimics the tumour microenvironment (TME), and normoxia–normoglycaemic conditions and found that in PDAC, PP inhibits mitochondrial energy metabolism through the inhibition of the NADH‐fumarate reductase (NADH‐FR) system.”
From Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti‐Pancreatic Cancer Activity in 2D and 3D Cell Culture Models (2024) · cites this paper as [11]
In the citing paper
“PP was previously shown to be effective under conditions that mimic the PDAC TME [10, 11, 12]”
From Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti‐Pancreatic Cancer Activity in 2D and 3D Cell Culture Models (2024) · cites this paper as [11]
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · cited 1×
“The protein concentrations were estimated using the Bradford method (23).”
MethodParkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
(1989) · PubMed · Cited by 3,343
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Regulation of cellular metabolism by protein lysine acetylation
Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., et al. (2010) · Science · doi:10.1126/science.1179689 · Cited by 1,910 · cited 1×
“These observations raise two questions: how does PP affect complex II and how does complex II differ under normal and tumour microenvironmental conditions? Post-translational modifications in mitochondrial proteins, such as phosphorylation and acetylation, have been identified and some of these modifications regulate…”
BackgroundPINK1-dependent recruitment of Parkin to mitochondria in mitophagy
Vives-Bauza, C., Zhou, C., Huang, Y., Cui, M., de Vries, R. L. A., Kim, J., May, J., Tocilescu, M. A., Liu, W., Ko, H. S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911187107 · Cited by 1,616
Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., Kinoshita, T., Saito, N., Ochiai, A., Tomita, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4806 · Cited by 956 · cited 1×
“Despite the limited glucose concentrations in tumour tissues in tumour microenvironments, the accumulation of amino acids has been observed in tumour tissues (3, 37).”
BackgroundSelf-citationTrounce, I. A., Kim, Y. L., Jun, A. S., & Wallace, D. C. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)64044-0 · Cited by 746
Drosophila Parkin requires PINK1 for mitochondrial translocation and ubiquitinates Mitofusin
Ziviani, E., Tao, R. N., & Whitworth, A. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913485107 · Cited by 735
Cited by
Chinopoulos, C. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23196 · Cited by 143
“…as part of an entity termed the ‘‘NAD1-fumarate reductase system’’ has been reported to occur in bacteria, lower eukaryotes, shellfish, and cancer cells (Kroger et al., 1992; Kita et al., 2007; Tomitsuka et al., 2009, 2010, 2012) and is composed of complex I and the reverse reaction of complex II.”
BackgroundSenkowski, W., Zhang, X., Olofsson, M. H., Isacson, R., Höglund, U., Gustafsson, M., Nygren, P., Linder, S., Larsson, R., & Fryknäs, M. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0792 · Cited by 141
“Pyrvinium pamoate, also an anthelmintic drug, targets the fumarate-reductase systemandhasbeenpreviously recognized for its high activity against spheroids and glucose-deprived cells (32, 33).”
BackgroundROCK inhibitors upregulate the neuroprotective Parkin-mediated mitophagy pathway
Moskal, N., Riccio, V., Bashkurov, M., Taddese, R., Datti, A., Lewis, P. N., & Angus McQuibban, G. (2020) · Nature Communications · doi:10.1038/s41467-019-13781-3 · Cited by 142
Cancer Usurps Skeletal Muscle as an Energy Repository
Luo, Y., Yoneda, J., Ohmori, H., Sasaki, T., Shimbo, K., Eto, S., Kato, Y., Miyano, H., Kobayashi, T., Sasahira, T., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1052 · Cited by 112
Inaoka, D. K., Shiba, T., Sato, D., Balogun, E. O., Sasaki, T. G., Nagahama, M., Oda, M., Matsuoka, S., Ohmori, J., Honma, T., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160715287 · Cited by 113
Self-citationIron chelators target both proliferating and quiescent cancer cells
Fryknäs, M., Zhang, X., Bremberg, U., Senkowski, W., Olofsson, M. H., Brandt, P., Persson, I., D’Arcy, P., Gullbo, J., Nygren, P., et al. (2016) · Scientific Reports · doi:10.1038/srep38343 · Cited by 82
Pyrvinium Attenuates Hedgehog Signaling Downstream of Smoothened
Li, B., Fei, D. L., Flaveny, C. A., Dahmane, N., Baubet, V., Wang, Z., Bai, F., Pei, X.-H., Rodriguez-Blanco, J., Hang, B., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0317 · Cited by 76
Teguh, S. C., Klonis, N., Duffy, S., Lucantoni, L., Avery, V. M., Hutton, C. A., Baell, J. B., & Tilley, L. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400656s · Cited by 76
The novel role of pyrvinium in cancer therapy
Momtazi‐borojeni, A. A., Abdollahi, E., Ghasemi, F., Caraglia, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26006 · Cited by 75
“Interestingly, pyrvinium was reported to inhibit NADH-fumarate reductase pathway in mitochondria of human cancer cells when cultured under hypoxia-hypoglycemic conditions, whereas this effect was not observed during normoxia-normoglycemic condition (Tomitsuka et al., 2012).”
BackgroundGlioma cells require one-carbon metabolism to survive glutamine starvation
Tanaka, K., Sasayama, T., Nagashima, H., Irino, Y., Takahashi, M., Izumi, Y., Uno, T., Satoh, N., Kitta, A., Kyotani, K., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01114-1 · Cited by 66
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers
Ahmed, K., Shaw, H., Koval, A., & Katanaev, V. L. (2016) · Cancers · doi:10.3390/cancers8070066 · Cited by 67
“Several other mechanisms, such as the energy metabolism and STAT3 pathway [144,145], glucose deprivation and hypoxia [146], as well as autophagy [147], have been implicated in the anticancer action of pyrvinium.”
BackgroundDrug Repurposing for Cancer Treatment: A Comprehensive Review
Khzem, A. H. A., Gomaa, M. S., Alturki, M. S., Tawfeeq, N., Sarafroz, M., Alonaizi, S. M., Faran, A. A., Alrumaihi, L. A., AlAnsari, F., & Alghamdi, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212441 · Cited by 65
Pyrvinium targets autophagy addiction to promote cancer cell death
Deng, L., Lei, Y., Liu, R., Li, J., Yuan, K., Li, Y., Chen, Y., Liu, Y., Lu, Y., Edwards III, C. K., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.142 · Cited by 59
“The modest effects on body weights and liver size appear to be related to the reported adverse effects of orally administered pyrvinium.(22)”
BackgroundMitochondria and Antibiotics: For Good or for Evil?
Suarez-Rivero, J. M., Pastor‐Maldonado, C. J., Povea-Cabello, S., Álvarez-Córdoba, M., Villalón-García, I., Talaverón-Rey, M., Suárez-Carrillo, A., Munuera-Cabeza, M., & Sánchez-Alcázar, J. A. (2021) · Biomolecules · doi:10.3390/biom11071050 · Cited by 61
“Pyrvinium pamoate Anthelmintic Inhibit cancer proliferation [40,267] Mitochondrial respiration inhibition [268] 1000 11 per kilogram”
BackgroundIshii, I., Harada, Y., & Kasahara, T. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00137 · Cited by 56
“The precise molecular mechanisms of the effects of PP remain unclear, but PP may influence the phosphorylation status of the flavoprotein subunit in complex II through the activation of mitochondrial phosphatase(s) (Tomitsuka et al., 2012).”
BackgroundOgawa, T., Washio, J., Takahashi, T., Echigo, S., & Takahashi, N. (2014) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2014.04.003 · Cited by 59
Guo, J., Lv, J., Chang, S., Chen, Z., Lu, W., Xu, C., Liu, M., & Pang, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9932 · Cited by 53
“Pyrvinium pamoate has been reported to suppress mitochondrial energy metabolism by inhibiting the NADH-fumarate reductase system [25].”
BackgroundSuccinate in ischemia: Where does it come from?
Chinopoulos, C. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.105580 · Cited by 59
Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors
Zhang, X., Milito, A. D., Olofsson, A. M., Gullbo, J., D’Arcy, P., & Linder, S. T. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161126020 · Cited by 59
Wang, H., Huwaimel, B., Verma, K., Miller, J. E., Germain, T., Kinarivala, N., Pappas, D., Brookes, P. S., & Trippier, P. C. (2017) · ChemMedChem · doi:10.1002/cmdc.201700196 · Cited by 58
Sanders, N. G., Sullivan, D. J., Mlambo, G., Dimopoulos, G., & Tripathi, A. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105817 · Cited by 56
“Homidium bromide (ethidium bromide) is a well-known fluorescent DNA-intercalating agent used in molecular biology and is known to be mutagenic, whereas pyrvinium pamoate is an FDAapproved anthelminthic compound used to treat pinworm, with activity against Cryptosporidium parvum, and thought to inhibit mitochondrial NA…”
BackgroundHardeman, K. N., Peng, C., Paudel, B. B., Meyer, C. T., Luong, T., Tyson, D. R., Young, J. D., Quaranta, V., & Fessel, J. P. (2017) · Scientific Reports · doi:10.1038/srep42604 · Cited by 51
“Furthermore, the cells were sensitive to the antihelminthic pyrvinium pamoate, which targets mitochondrial function under various conditions 22 , particularly glucose deprivation 23 .”
Dattilo, R., Mottini, C., Camera, E., Lamolinara, A., Auslander, N., Doglioni, G., Muscolini, M., Tang, W., Planque, M., Ercolani, C., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-1184 · Cited by 49
“PP (CAS: 3546-41-6, Figure 1A) was initially identified as an inhibitor of multiple mitochondria electron transport chain (ETC) complexes, wherein it targets both complexes I and II (13,14), resulting in reduced mitochondria fitness.”
BackgroundCarrella, D., Manni, I., Tumaini, B., Dattilo, R., Papaccio, F., Mutarelli, M., Sirci, F., Amoreo, C. A., Mottolese, M., Iezzi, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11318 · Cited by 47
“Among selected drugs (Table 1), we focused our attention on Niclosamide (Niclo) and Pyrvinium Pamoate (PP), two FDA-approved anthelmintic drugs, as a result of following considerations: i) recent preclinical data have outlined anticancer effects of both compounds in several in vitro and in vivo cancer models [29-33];…”
BackgroundTargeting Mitochondria in Melanoma
Aminzadeh-Gohari, S., Weber, D. D., Catalano, L., Feichtinger, R. G., Kofler, B., & Lang, R. (2020) · Biomolecules · doi:10.3390/biom10101395 · Cited by 47
“In vitro and in vivo studies showed that PP inhibits proliferation of different types of cancer, including solid tumors and blood cancers, by reducing mitochondrial respiration [31,52,76,77].”
BackgroundPyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer Drug
Schultz, C. W., & Nevler, A. (2022) · Biomedicines · doi:10.3390/biomedicines10123249 · Cited by 44
“[77] have also shown that PP treatment of cancer cells (Panc-1, DLD-1, HepG2) resulted in the inhibition of the NADH–fumarate reductase system, a system primarily associated with cancer metabolism in dually hypoxic and hypoglycemic conditions, and increased activity of complex II (succinate–ubiquinone reductase).”
BackgroundDatta, S., Sears, T. K., Cortopassi, G. A., Woolard, K., & Angelastro, J. M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111058 · Cited by 40
“Pyrvinium pamoate impairs the reversal mitochondrial electron-transport chain complex, NADH-fumarate reductase system under hypoglycemic and hypoxic conditions found in tumor microenvironments [65].”
BackgroundChano, T., Avnet, S., Kusuzaki, K., Bonuccelli, G., Sonveaux, P., Rotili, D., Mai, A., & Baldini, N. (2016) · PubMed · Cited by 39
Simm, C., Weerasinghe, H., Thomas, D. R., Harrison, P. F., Newton, H. J., Beilharz, T. H., & Traven, A. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00100-22 · Cited by 38
“The cytotoxicity of PP against cancer cells and cardiac fibroblast was dramatically increased in low-glucose conditions (47, 63, 68), consistent with higher reliance on glycolysis”
BackgroundDiversity of parasite complex II
Harada, S., Inaoka, D. K., Ohmori, J., & Kita, K. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2013.01.005 · Cited by 38
Self-citationFrom old to new — Repurposing drugs to target mitochondrial energy metabolism in cancer
Aminzadeh-Gohari, S., Weber, D. D., Vidali, S., Catalano, L., Kofler, B., & Feichtinger, R. G. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.025 · Cited by 38
“Pyrvinium pamoate, an anti-pinworm and anti-malarial medication, inhibits the mitochondrial NADH-fumarate reductase system, which is composed of complex I and II [39,45,67,68].”
BackgroundThe impact of pyrvinium pamoate on colon cancer cell viability
Wiegering, A., Uthe, F.-W., Hüttenrauch, M., Mühling, B., Linnebacher, M., Krummenast, F., Germer, C.-T., Thalheimer, A., & Otto, C. (2014) · International Journal of Colorectal Disease · doi:10.1007/s00384-014-1975-y · Cited by 37
“Tomitsuka proposed that PP disrupts energy metabolism by interfering with the NADH-fumarate reductase system [22, 23].”
A “Weird” Mitochondrial Fatty Acid Oxidation as a Metabolic “Secret” of Cancer
Zhelev, Z., Aoki, I., Lazarova, D., Vlaykova, T. I., Higashi, T., & Bakalova, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2339584 · Cited by 36
“In 2012, the same authors demonstrated that glucose deprivation without hypoxia also induces reversal of SDH-reaction [105].”
BackgroundMurakoshi, M., Saiki, K., Urayama, K., & Sato, T. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079374 · Cited by 36
Antiparasitic effects of selected isoflavones on flatworms
Faixová, D., Hrčková, G., Kubašková, T. M., & Mudroňová, D. (2021) · Helminthologia · doi:10.2478/helm-2021-0004 · Cited by 35
“It is a unique enzymatic system for energy generation, not found in normal eukaryotic cells, except for cancer cells (Tomitsuka et al., 2012).”
BackgroundSchultz, C. W., McCarthy, G. A., Nerwal, T., Nevler, A., DuHadaway, J. B., McCoy, M. D., Jiang, W., Brown, S. Z., Goetz, A., Jain, A., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0652 · Cited by 34
“Previous work proposed that PP inhibits fumarate reductase, a critical member in an alternative mitochondrial pathway proposed to function in cancer cells in hypoxic conditions whereby mitochondria can generate ATP in an oxygenindependent fashion (12).”
BackgroundThomas, S., Sharma, N., Gonzalez, R., Pao, P.-W., Hofman, F. M., Chen, T. C., Louie, S. G., Pirrung, M. C., & Schönthal, A. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065695 · Cited by 34
“Arctigenin [61], pyrvinium [62] and metformin [63,64] have demonstrated ETC inhibitory activity.”
BackgroundSureshkumar, B., Mary, Y. S., Panicker, C. Y., Resmi, K. S., Suma, S., Armaković, S., Armaković, S. J., & Alsenoy, C. V. (2017) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2017.09.014 · Cited by 32
López‐Cortés, A., Cabrera‐Andrade, A., Echeverría‐Garcés, G., Echeverría-Espinoza, P., Pineda-Albán, M., Elsitdie, N., Bueno‐Miño, J., Segundo, C. M. C., Dorado, J., Pazos, A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-68565-7 · Cited by 31
Liu, W., Yang, F., Zhang, R., Shi, X., Lu, X., Luan, Y., Xiu, Z., & Dong, Y. (2016) · Phytochemistry Letters · doi:10.1016/j.phytol.2016.10.006 · Cited by 30
Fredericks, W. J., Yin, H., Lal, P., Raghunath, P. N., Malkowicz, S. B., Fredericks, N., Tomaszewski, J., Rauscher, F. J., & Malkowicz, S. B. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1985 · Cited by 30
Novel Characteristics of Mitochondrial Electron Transport Chain from Eimeria tenella
Matsubayashi, M., Inaoka, D. K., Komatsuya, K., Hatta, T., Kawahara, F., Sakamoto, K., Hikosaka, K., Yamagishi, J., Sasai, K., Shiba, T., et al. (2019) · Genes · doi:10.3390/genes10010029 · Cited by 28
“In order to re-oxidize quinols, complex II starts to function as QFR in a process called fumarate respiration, which is found in bacteria [55], helminthes [9,56], and also in some types of cancer cells living under a tumor microenvironment [11,30,36,57,58].”
BackgroundSelf-citationTalaam, K., Inaoka, D. K., Hatta, T., Tsubokawa, D., Tsuji, N., Wada, M., Saimoto, H., Kita, K., & Hamano, S. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00418-21 · Cited by 26
“We previously showed that ascofuranone (61) and pyrvinium pamoate (23) inhibit helminth fumarate respiration.”
BackgroundSelf-citationCritical Role of H2O2 Generated by NOX4 during Cellular Response under Glucose Deprivation
Owada, S., Shimoda, Y., Tsuchihara, K., & Esumi, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056628 · Cited by 26
“The glucose-deprived condition was created as described previously [16].”
MethodSelf-citationTakahashi, E., & Sato, M. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00255.2013 · Cited by 25
Blocking STAT3 by pyrvinium pamoate causes metabolic lethality in KRAS-mutant lung cancer
Feng, J., Jiang, W., Liu, Y., Huang, W., Hu, K., Li, K., Chen, J., Ma, C., Sun, Z., & Pang, X. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113960 · Cited by 23
Drug Repurposing Strategies for Non-cancer to Cancer Therapeutics
Singhal, S., Maheshwari, P., Krishnamurthy, P. T., & Patil, V. M. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220317140557 · Cited by 22
Repurposing of Anthelminthics as Anticancer Drugs
Hamilton, G., & Rath, B. (2017) · Oncomedicine · doi:10.7150/oncm.20563 · Cited by 22
“Aside of the inhibition of signal transduction, on-target repositioning assumes that the targets recognized in nematods, such as mitochondrial respiration and microtubules, are hit in cancer cells [70, 89, 90].”
BackgroundSakai, C., Tomitsuka, E., Miyagishi, M., Harada, S., & Kita, K. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.08.009 · Cited by 20
Self-citationGuan, Q., Zhan, L., Liu, Z., Pan, Q., Chen, X., Xiao, Z., Qin, C., & Zhang, X. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1720527 · Cited by 18
“It has been reported that PP inhibited the nicotinamide adenine dinucleotide (reduced form, NADH) in the respiratory chain and thus play an anti-tumor effect [30,31].”
BackgroundEvolutionary Adaptations of Parasitic Flatworms to Different Oxygen Tensions
Martínez-González, J. D. J., Guevara‐Flores, A., & Mena, I. P. D. A. (2022) · Antioxidants · doi:10.3390/antiox11061102 · Cited by 18
Khan, M. A., Wood, P. J., Lamb-Guhren, N. M., Caggiano, L., Kociok-Köhn, G. I., Tosh, D., & Lewis, S. E. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.04.111 · Cited by 18
Toxic Effects of Penetrating Cations
Соколов, С. С., Zyrina, A. N., Akimov, S. A., Кнорре, Д. А., & Severin, F. F. (2023) · Membranes · doi:10.3390/membranes13100841 · Cited by 17
“Fumarate reductase [38] and mitochondrial DNA [39] were reported as others.”
BackgroundFu, Y.-H., Tseng, C.-Y., Lu, J., Lu, W., Lan, P.-Q., Chen, C., Ou, D., & Lin, L. (2021) · Biomedicines · doi:10.3390/biomedicines9121869 · Cited by 15
“The following mechanisms have been elucidated: (1) through the allosteric activation of casein kinase 1α and the destabilization of β-catenin in wingless-related integration site (Wnt) pathways [14,15], as well as related Hedgehog signaling pathways [16]; (2) through the inhibition of the phosphoinositide 3-kinase (PI…”
BackgroundInfluentialCheng, V. W. T., Tran, Q. M., Boroumand, N., Rothery, R. A., Maklashina, E., Cecchini, G., & Weiner, J. H. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2013.05.004 · Cited by 15
Detection of NAD(P)H-dependent enzyme activity by time-domain ratiometry of terbium luminescence
Terai, T., Ito, H., Hanaoka, K., Komatsu, T., Ueno, T., Nagano, T., & Urano, Y. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.03.038 · Cited by 14
Nair, R. R., Piktel, D., Hathaway, Q. A., Rellick, S. L., Thomas, P., Saralkar, P. A., Martin, K. H., Geldenhuys, W. J., Hollander, J. M., & Gibson, L. F. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-2767-4 · Cited by 13
“The complete mechanism of PP-mediated leukemic cell death includes its ability to inhibit ATP production in addition to its mitochondrial inhibitory activity (13,14,29,30).”
BackgroundMethodDiscovery of Halogenated Benzothiadiazine Derivatives with Anticancer Activity**
Huwaimel, B., Bhakta, M., Kulkarni, C. A., Milliken, A. S., Wang, F., Peng, A., Brookes, P. S., & Trippier, P. C. (2020) · ChemMedChem · doi:10.1002/cmdc.202000729 · Cited by 13
Metabolic modulation of mitochondrial mass during CD4+ T cell activation
Kurmi, K., Liang, D., van de Ven, R., Georgiev, P., Gassaway, B. M., Han, S., Notarangelo, G., Harris, I. S., Yao, C.-H., Park, J. S., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.08.008 · Cited by 12
Liu, W.-C., Ren, Y., Hao, A.-Y., Sun, Y., Shi, X., Zhang, X., Xing, Y., Xiu, Z., Cui, Y., & Dong, Y. (2018) · The Journal of Antibiotics · doi:10.1038/s41429-018-0061-z · Cited by 9
Rodgers, S. J., Ooms, L. M., & Mitchell, C. A. (2022) · Cancers · doi:10.3390/cancers15010135 · Cited by 8
Cancer Stem Cell Case and Evolutionary Paradigm
Ivanović, Z., & Vlaski‐Lafarge, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800540-8.00014-4 · Cited by 8
Vlaski‐Lafarge, M., Labat, V., Brandy, A., Refeyton, A., Duchez, P., Rodríguez, L., Gibson, N., de la Grange, P. B., & Ivanović, Z. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00713 · Cited by 8
“The mechanism described includes the use of fumarate as the final electron acceptor (fumarate respiration or “disproportionation of malate”) (14).”
Serala, K., Bai, J., & Prince, S. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70222 · Cited by 6
Tomita, R., Todoroki, K., Hayama, T., Yoshida, H., Fujioka, T., Nakashima, M., Yamaguchi, M., & Nohta, H. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00746 · Cited by 5
Nair, R. R., Piktel, D., Thomas, P., Hathaway, Q. A., Rellick, S. L., Saralkar, P. A., Martin, K. H., Geldenhuys, W. J., Hollander, J. M., & Gibson, L. F. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/595959 · Cited by 2
Development of WNT inhibitors as novel anti-cancer drugs
SHAW, H. V. (2020) · IRIS · Cited by 1
Metabolic Peculiarities of the Stem Cell Entity
Ivanović, Z., & Vlaski‐Lafarge, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800540-8.00006-5
Exploring vulnerabilities of quiescent tumor cells by targeting mitochondrial bioenergetics
Linder, S. T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819621-2.00025-5
Dattilo, R., Mottini, C., Camera, E., Lamolinara, A., Auslander, N., Doglioni, G., Muscolini, M., Tang, W., Planque, M., Ercolani, C., et al. (2023) · doi:10.1158/0008-5472.c.6511812.v1
Senkowski, W., Zhang, X., Olofsson, M. H., Isacson, R., Höglund, U., Gustafsson, M. G., Nygren, P., Linder, S. T., Larsson, R. L., & Fryknäs, M. (2023) · doi:10.1158/1535-7163.c.6536653.v1
Schultz, C. W., McCarthy, G. A., Nerwal, T., Nevler, A., DuHadaway, J. B., McCoy, M., Jiang, W., Brown, S. Z., Goetz, A. B., Jain, A., et al. (2023) · doi:10.1158/1535-7163.c.6543201.v1
Amin, T., Shishir, M. A., Alam, M. M., Anam, M. B., Bulbul, N., Jime, J. S., & Fakruddin, M. (2025) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265362556250717063603
Beyond antiparasitic activity: elucidating the antibacterial potency of pyrvinium pamoate
Alcaraz-Martínez, Á., Muñoz-Báez, P., Peñalver, P., Morales, J. C., & Cebrián, R. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02158-25
“In addition to targeting Wnt signaling, PP has been shown to exert cytotoxic effects through alterations in mitochondrial function and energy metabolism, apparently imitating its parasiticidal properties (16).”
Additional file 1 of Glioma cells require one-carbon metabolism to survive glutamine starvation
Tanaka, K., Sasayama, T., Nagashima, H., Irino, Y., Takahashi, M., Izumi, Y., Uno, T., Satoh, N., Kitta, A., Kyotani, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13612770
Additional file 2 of Glioma cells require one-carbon metabolism to survive glutamine starvation
Tanaka, K., Sasayama, T., Nagashima, H., Irino, Y., Takahashi, M., Izumi, Y., Uno, T., Satoh, N., Kitta, A., Kyotani, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13612773
Design, Synthesis and Antineoplastic Evaluation of a Variety of Small Molecule Scaffolds
Huwaimel, B. (2021) · DigitalCommons@UNMC
Kumar, R., & Ansari, M. Y. (2026) · RSC Medicinal Chemistry · doi:10.1039/d6md00084c
三上, 貴. (2016) · Institutional Repositories DataBase (IRDB) · doi:10.15083/00073664
大森, 厚. (2013) · Institutional Repositories DataBase (IRDB) · doi:10.15083/00005474
Al‐Zoubi, R. M., Farhan, A., Hanbali, B., Al-Zoubi, S. R., Khan, A., Shkoor, M., Bani‐Yaseen, A. D., Zoubi, M. S. A., & Agouni, A. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118987
Metadata
- Authors
- Tomitsuka, E., Kita, K., & Esumi, H.
- Affiliations
- National Cancer Centre Japan (JP)
- Corresponding author
- Tomitsuka, Eriko
- Venue
- The Journal of Biochemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-04-23
- Volume
- 152
- Issue
- 2
- Pages
- 171-183
- ISSN
- 0021-924X (ISSN-L)
- 1756-2651
- OpenAlex
- W2142261125
- Cited by
- 79
- References
- 50
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 5 · 2022: 6 · 2021: 8 · 2020: 10 · 2019: 4 · 2018: 2 · 2017: 5 · 2016: 7 · 2015: 6 · 2014: 5 · 2013: 12 · 2012: 1
- FWCI
- 2.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Hirosaki University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- pyrvinium pamoate, mitochondrial bioenergetics, tumor microenvironment, hypoxia, hypoglycemia, cancer cell energy metabolism, NADH-ubiquinone reductase, succinate-ubiquinone reductase, NADH oxidase, therapeutic target
- MeSH terms
- Animals, Hypoxia, Anthelmintics, Antineoplastic Agents, Cattle, Energy Metabolism, Enzyme Inhibitors, Humans, Hypoglycemia, Mitochondria, Mitochondria, Heart, Pyrvinium Compounds, Tumor Cells, Cultured, Cell Hypoxia, Ascaris suum, Electron Transport Complex II, Oxidoreductases Acting on CH-CH Group Donors, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.